Smart Health Technology is equipped to automatically obtain, store and compute health information from technically advanced sensors and offer personalised advice or automated actions from the collected data. Smart Health Technology has the capability to interact and engage with data via Virtual or Augmented Reality to provide even more real time experience for both physicians and patients.
There are numerous opportunities for healthcare stakeholders/manufacturers to innovate Smart Health Technology solutions, which are expected to streamline the precise medical care approach, e.g. telemedicine. However, there are also certain restraints such as infrastructure and competencies required to integrate Smart Health Technologies in regular healthcare maneuvers. Moreover, the manufacturers and service providers need to ensure data security and adhere global standards. Few of the latest applications of Smart Health Technology are Smart Pill, Smart Syringe, Intelligent Fabric, and Smart Wearable Devices.
Smartphone users count is expected to surpass to 2.5 billion by 2019. This exponential growth is expected to influence the fate of health and fitness apps, which have already increased by more than 30% since 2016. It is estimated that almost 75% of active mobile users run their health and fitness apps twice per week. With the advent of increased awareness, people are using technology to take more control of their health conditions such as asthma, infertility, obesity, and diabetes etc. Moreover, plethora of user data churned out from these apps is helping the market researchers access unparalleled volume of data for further in depth and precise insights.
Smart pill technology includes wireless capsule, a receiver, and the software, which investigates and categories the gathered information from the patient who consumes the pill. Smart pill is an emerging technology, which is witnessing an upsurge in demand and is expected to show significant potential in the diagnostics domain in the future. The technology is used to detect gastrointestinal (GI) conditions and provide the physicians with information relating to several parameters such as pH, temperature and GI tract pressure. The smart pill technology domain can be segmented into Capsule endoscopy System, Drug Delivery System and Patient Monitoring Devices.
In November 2017, the US FDA approved the first digital pill, Abilify MyCite, to track patients’ medication data. Abilify MyCite is a venture between Otsuka and Proteus Digital Health (digital medicine service provider). The major players operating in the smart pill technologies market include Novartis AG, Given Imaging Ltd., Philips Healthcare, Smartpill Inc., Olympus Medical Technology, Medtronic, Pentax Medical Co., Siemens Healthineers, Stryker Corp., GE Healthcare, and Boston Scientific Corp.
Smart wearable medical devices are small electronic products (comprise of sensors) which have computational competence. These devices are entrenched into items, which are attached to different body parts of the user. These smart wearables can resemble watches, eyeglasses, clothing, contact lenses, shoes, or even jewelleries.
Few of the latest smart health monitoring wearables are mentioned below:
- Pebble Health (health monitoring app)
- Zephyr BioPatch (wireless monitoring device)
- Muse headband (brain-sensing monitoring headband)
- AliveCor Heart Monitor (smartphone-based ECG device)
- Garmin Forerunner 935 (GPS-enabled heart rate monitoring device)
Apple Watch Series 4, which automatically informs to hospital services if an user becomes immobile for a certain period of time. These devices are assisting individuals to become healthier, simultaneously storing real-time data which can be analysed by healthcare professionals via remote patient monitoring, ensuing more precise and perceptive data for better healthcare practices. Moreover, AI has the ability to continuously monitor healthcare data and transfer the same to hospitals when necessary.
– Victor Mukherjee,